Variant report

Variant	esv3437961
Chromosome Location	chr6:150182459-150187257
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:939)
CpG islands
(count:919)
Chromatin interactive
region (count:22)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:939 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:150181723-150182947	HepG2	liver:	n/a	n/a
2	ARID3A	chr6:150186071-150186474	K562	blood:	n/a	n/a
3	ARID3A	chr6:150186002-150186469	HepG2	liver:	n/a	n/a
4	ARID3A	chr6:150186902-150187063	K562	blood:	n/a	n/a
5	ATF3	chr6:150184956-150185229	K562	blood:	n/a	n/a
6	BACH1	chr6:150185045-150185235	H1-hESC	embryonic stem cell:	n/a	n/a
7	BACH1	chr6:150186131-150186460	H1-hESC	embryonic stem cell:	n/a	n/a
8	BACH1	chr6:150185584-150185784	H1-hESC	embryonic stem cell:	n/a	n/a
9	BACH1	chr6:150186225-150186514	K562	blood:	n/a	n/a
10	BACH1	chr6:150184213-150184496	H1-hESC	embryonic stem cell:	n/a	n/a
11	BHLHE40	chr6:150184918-150185520	K562	blood:	n/a	chr6:150185246-150185262 chr6:150185420-150185436
12	BHLHE40	chr6:150186110-150186409	K562	blood:	n/a	n/a
13	BHLHE40	chr6:150184309-150185887	HepG2	liver:	n/a	chr6:150185246-150185262 chr6:150184350-150184366 chr6:150185420-150185436
14	BHLHE40	chr6:150186116-150186415	HepG2	liver:	n/a	n/a
15	BHLHE40	chr6:150186087-150186340	GM12878	blood:	n/a	n/a
16	BHLHE40	chr6:150181795-150182660	HepG2	liver:	n/a	n/a
17	BRCA1	chr6:150185712-150185900	H1-hESC	embryonic stem cell:	n/a	n/a
18	BRCA1	chr6:150185381-150185579	HepG2	liver:	n/a	n/a
19	BRCA1	chr6:150184224-150184578	Hela-S3	cervix:	n/a	n/a
20	BRCA1	chr6:150185006-150185026	HepG2	liver:	n/a	n/a
21	BRCA1	chr6:150185423-150185667	Hela-S3	cervix:	n/a	n/a
22	CBX3	chr6:150185290-150185821	K562	blood:	n/a	n/a
23	CCNT2	chr6:150184406-150185741	K562	blood:	n/a	n/a
24	CEBPB	chr6:150182541-150182827	Hela-S3	cervix:	n/a	chr6:150182705-150182716
25	CEBPB	chr6:150182578-150182798	K562	blood:	n/a	chr6:150182705-150182716
26	CEBPB	chr6:150182466-150182956	MCF-7	breast:	n/a	chr6:150182705-150182716
27	CEBPB	chr6:150182552-150182888	A549	lung:	n/a	chr6:150182705-150182716
28	CEBPB	chr6:150182469-150182917	HepG2	liver:	n/a	chr6:150182705-150182716
29	CEBPB	chr6:150181851-150183198	HepG2	liver:	n/a	chr6:150182705-150182716
30	CEBPB	chr6:150182554-150182813	H1-hESC	embryonic stem cell:	n/a	chr6:150182705-150182716
31	CEBPB	chr6:150184008-150185779	Hela-S3	cervix:	n/a	chr6:150184098-150184115
32	CEBPB	chr6:150182485-150183266	IMR90	lung:	n/a	chr6:150182705-150182716
33	CEBPB	chr6:150185534-150185774	HepG2	liver:	n/a	n/a
34	CEBPB	chr6:150182527-150182901	HepG2	liver:	n/a	chr6:150182705-150182716
35	CEBPB	chr6:150183995-150184329	IMR90	lung:	n/a	chr6:150184098-150184115
36	CEBPB	chr6:150182542-150182866	K562	blood:	n/a	chr6:150182705-150182716
37	CEBPB	chr6:150182557-150182827	HepG2	liver:	n/a	chr6:150182705-150182716
38	CEBPB	chr6:150182407-150182968	A549	lung:	n/a	chr6:150182705-150182716
39	CEBPB	chr6:150182529-150182860	K562	blood:	n/a	chr6:150182705-150182716
40	CEBPB	chr6:150182461-150182944	MCF-7	breast:	n/a	chr6:150182705-150182716
41	CEBPB	chr6:150182551-150182840	A549	lung:	n/a	chr6:150182705-150182716
42	CEBPB	chr6:150184506-150184864	HepG2	liver:	n/a	n/a
43	CEBPD	chr6:150182531-150182876	HepG2	liver:	n/a	n/a
44	CEBPD	chr6:150185180-150185852	HepG2	liver:	n/a	n/a
45	CEBPD	chr6:150182483-150182934	HepG2	liver:	n/a	n/a
46	CHD1	chr6:150184564-150184631	H1-hESC	embryonic stem cell:	n/a	n/a
47	CHD1	chr6:150181747-150185902	IMR90	lung:	n/a	chr6:150185305-150185315
48	CHD1	chr6:150185016-150185767	H1-hESC	embryonic stem cell:	n/a	chr6:150185305-150185315
49	CHD2	chr6:150185444-150185849	H1-hESC	embryonic stem cell:	n/a	n/a
50	CHD2	chr6:150184306-150185780	Hela-S3	cervix:	n/a	chr6:150185305-150185315

(count:919 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:150184916-150184966	HNPCEpiC	eye:	n/a
2	chr6:150185488-150185538	GM06990	blood:	n/a
3	chr6:150184916-150184966	HCPEpiC	choroid plexus:	n/a
4	chr6:150183531-150183581	ProgFib	skin:	n/a
5	chr6:150184916-150184966	HNPCEpiC	eye:	n/a
6	chr6:150185488-150185538	GM06990	blood:	n/a
7	chr6:150184916-150184966	HCPEpiC	choroid plexus:	n/a
8	chr6:150183531-150183581	ProgFib	skin:	n/a
9	chr6:150183531-150183581	HAEpiC	amniotic membrane:	n/a
10	chr6:150185198-150185248	LNCaP	prostate:	n/a
11	chr6:150185499-150185549	ovcar-3	ovarian:	n/a
12	chr6:150185198-150185248	PFSK-1	brain:	n/a
13	chr6:150183531-150183581	HNPCEpiC	eye:	n/a
14	chr6:150185488-150185538	RPTEC	kidney:	n/a
15	chr6:150185632-150185682	SK-N-SH_RA	brain:	n/a
16	chr6:150185854-150185904	HEK293	kidney:	embryo
17	chr6:150184345-150184395	AG10803	skin:	n/a
18	chr6:150185369-150185419	GM12892	blood:	n/a
19	chr6:150185488-150185538	HCPEpiC	choroid plexus:	n/a
20	chr6:150185501-150185551	HIPEpiC	eye:	n/a
21	chr6:150185499-150185549	K562	blood:	n/a
22	chr6:150185501-150185551	Caco-2	colon:	n/a
23	chr6:150185632-150185682	AG09319	gingival:	n/a
24	chr6:150184345-150184395	HCT-116	colon:	n/a
25	chr6:150185369-150185419	AG04450	lung:	fetal
26	chr6:150184345-150184395	HRPEpiC	eye:	n/a
27	chr6:150185198-150185248	Hepatocyte	liver:	n/a
28	chr6:150185854-150185904	HNPCEpiC	eye:	n/a
29	chr6:150184916-150184966	HEEpiC	esophagus:	n/a
30	chr6:150185369-150185419	HPAEpiC	pulmonary alveolar:	n/a
31	chr6:150185632-150185682	IMR90	lung:	fetal
32	chr6:150184969-150185019	CMK	blood:	n/a
33	chr6:150185499-150185549	PrEC	prostate:	n/a
34	chr6:150185854-150185904	AG10803	skin:	n/a
35	chr6:150184138-150184188	GM06990	blood:	n/a
36	chr6:150185499-150185549	HAEpiC	amniotic membrane:	n/a
37	chr6:150185198-150185248	NH-A	brain:	n/a
38	chr6:150185595-150185645	AoSMC	blood vessel:	n/a
39	chr6:150185499-150185549	AG09319	gingival:	n/a
40	chr6:150185809-150185859	ovcar-3	ovarian:	n/a
41	chr6:150185632-150185682	U87	brain:	n/a
42	chr6:150183516-150183566	ProgFib	skin:	n/a
43	chr6:150185595-150185645	HL-60	blood:	n/a
44	chr6:150185499-150185549	NT2-D1	testis:	n/a
45	chr6:150185198-150185248	HPAEpiC	pulmonary alveolar:	n/a
46	chr6:150185809-150185859	HRPEpiC	eye:	n/a
47	chr6:150185854-150185904	HIPEpiC	eye:	n/a
48	chr6:150185198-150185248	HMEC	breast:	n/a
49	chr6:150185632-150185682	SK-N-SH	brain:	n/a
50	chr6:150185488-150185538	HMEC	breast:	n/a

(count:22 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:150183832..150186232-chr6:150215270..150224001,9	MCF-7	breast:
2	chr6:150161791..150162424-chr6:150182291..150183108,3	MCF-7	breast:
3	chr6:150156036..150158963-chr6:150184147..150187311,3	MCF-7	breast:
4	chr6:150183161..150188305-chr6:150206346..150214162,9	MCF-7	breast:
5	chr6:150180705..150183477-chr6:150200209..150201991,2	K562	blood:
6	chr6:150065257..150067789-chr6:150184620..150186500,2	K562	blood:
7	chr6:149865631..149868201-chr6:150184694..150186592,2	MCF-7	breast:
8	chr6:150037040..150038886-chr6:150185486..150187035,2	K562	blood:
9	chr6:150168942..150171816-chr6:150186693..150188431,2	K562	blood:
10	chr6:149967481..149969834-chr6:150184237..150185789,2	K562	blood:
11	chr6:150186302..150188604-chr6:150204580..150207263,3	MCF-7	breast:
12	chr6:150184661..150189239-chr6:150198084..150201371,4	MCF-7	breast:
13	chr12:7053047..7053870-chr6:150185072..150185791,2	Hela-S3	cervix:
14	chr6:150036146..150038991-chr6:150182749..150185016,3	K562	blood:
15	chr6:150037075..150038991-chr6:150181496..150184249,2	K562	blood:
16	chr6:150167839..150171816-chr6:150186693..150189063,3	K562	blood:
17	chr6:150186409..150189034-chr6:150239066..150241266,2	MCF-7	breast:
18	chr6:150067770..150069561-chr6:150184088..150185718,2	MCF-7	breast:
19	chr2:174828821..174830614-chr6:150186810..150189334,2	MCF-7	breast:
20	chr6:150185187..150186828-chr6:150215109..150217579,2	MCF-7	breast:
21	chr6:150181490..150187274-chr6:150243970..150248410,8	MCF-7	breast:
22	chr6:150155308..150156178-chr6:150182507..150183228,2	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ULBP2-3	chr6:150185338-150185480	NONHSAT115516
2	lnc-RAET1E-2	chr6:150184027-150184273	expReg_chr6_11262_-

No data

Variant related genes	Relation type
ENSG00000268592	TF binding region
LRP11	TF binding region
ENSG00000268592	CpG island
LRP11	CpG island
ENSG00000223701	chromatin interactions
ENSG00000131013	chromatin interactions
ENSG00000164520	chromatin interactions
ENSG00000217733	chromatin interactions
ENSG00000272173	chromatin interactions
ENSG00000111678	chromatin interactions
ENSG00000120256	chromatin interactions
ENSG00000186625	chromatin interactions
ENSG00000172845	chromatin interactions
ENSG00000203722	chromatin interactions
ENSG00000120253	chromatin interactions
ENSG00000131023	chromatin interactions

Extended variants
information (count: 142 )
Associated
traits (count: 84 )

Variant overlapped rSNPs/rCNVs (count:142 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs530202939	chr6:150182486-150182487	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
2	rs186323394	chr6:150182526-150182527	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
3	rs191624897	chr6:150182527-150182528	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
4	rs563266914	chr6:150182543-150182544	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
5	rs1537589	chr6:150182565-150182566	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
6	rs532007126	chr6:150182581-150182582	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
7	rs76072271	chr6:150182614-150182615	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
8	rs1537590	chr6:150182629-150182630	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
9	rs534426185	chr6:150182641-150182642	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
10	rs181296836	chr6:150182650-150182651	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
11	rs568286201	chr6:150182691-150182692	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
12	rs537211673	chr6:150182739-150182740	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
13	rs557328785	chr6:150182753-150182754	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
14	rs551327147	chr6:150182771-150182772	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
15	rs138834120	chr6:150182774-150182775	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
16	rs559228650	chr6:150182811-150182812	Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
17	rs201278963	chr6:150182832-150182833	Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
18	rs528332387	chr6:150182844-150182845	Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
19	rs185935299	chr6:150182966-150182967	Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
20	rs117987883	chr6:150182993-150182994	Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Strong transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
21	rs554609137	chr6:150183004-150183005	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Active TSS Strong transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
22	rs190700667	chr6:150183047-150183048	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Active TSS Strong transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
23	rs543587296	chr6:150183067-150183068	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Active TSS Strong transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
24	rs368892460	chr6:150183089-150183090	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Active TSS Strong transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
25	rs563684998	chr6:150183129-150183130	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Active TSS Strong transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
26	rs532683312	chr6:150183138-150183139	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Active TSS Strong transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
27	rs73779598	chr6:150183161-150183162	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Active TSS Strong transcription	TF binding region Chromatin interactive region	6 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs113511505	chr6:150183175-150183176	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Active TSS Strong transcription	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
29	rs73779599	chr6:150183197-150183198	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Active TSS Strong transcription	TF binding region Chromatin interactive region	6 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs547998506	chr6:150183222-150183223	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Active TSS Strong transcription	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
31	rs79267012	chr6:150183287-150183288	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Active TSS Strong transcription	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
32	rs373435284	chr6:150183291-150183292	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Active TSS Strong transcription	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
33	rs35586124	chr6:150183326-150183327	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Active TSS Strong transcription	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
34	rs551179083	chr6:150183437-150183438	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Genic enhancers	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
35	rs114079085	chr6:150183452-150183453	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Genic enhancers	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
36	rs550793044	chr6:150183518-150183519	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
37	rs183285633	chr6:150183522-150183523	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
38	rs570802222	chr6:150183576-150183577	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
39	rs9371502	chr6:150183603-150183604	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs553186265	chr6:150183676-150183677	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
41	rs375619712	chr6:150183686-150183687	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
42	rs201883603	chr6:150183707-150183708	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
43	rs200222844	chr6:150183711-150183712	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
44	rs369463509	chr6:150183713-150183714	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
45	rs67569936	chr6:150183714-150183715	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
46	rs10553273	chr6:150183732-150183733	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
47	rs9478192	chr6:150183737-150183738	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
48	rs188010639	chr6:150183759-150183760	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
49	rs554670765	chr6:150183809-150183810	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
50	rs574588800	chr6:150183828-150183829	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:84)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Autism	22495311	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Follicular lymphoma	20505157	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
Renal cell carcinoma	18592004	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Malignant melanoma	17260012	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Soft tissue tumor	16732325	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
Cancer	17160897	CNVD
Breast cancer	17417639	CNVD
Breast cancer	17850661	CNVD
Renal cell carcinoma	18765545	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Breast cancer	21804112	CNVD
Myelofibrosis	22110671	CNVD
Ovarian neoplasms	16753589	CNVD
Retinoblastoma	22278416	CNVD
Breast cancer	20556506	CNVD
Hirschsprung''s Disease	21712996	CNVD
Testicular germ cell tumor	18059402	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:606 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:150155800-150182600	Weak transcription	Dnd41	blood
2	chr6:150168800-150182600	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
3	chr6:150168800-150183400	Weak transcription	Rectal Smooth Muscle	rectum
4	chr6:150169200-150183000	Weak transcription	Brain Substantia Nigra	brain
5	chr6:150169400-150183200	Weak transcription	Cortex derived primary cultured neurospheres	brain
6	chr6:150173000-150184200	Weak transcription	Aorta	Aorta
7	chr6:150173200-150183200	Weak transcription	Ovary	ovary
8	chr6:150174200-150182600	Weak transcription	Fetal Muscle Trunk	muscle
9	chr6:150176200-150183200	Weak transcription	Fetal Intestine Large	intestine
10	chr6:150176600-150183200	Weak transcription	Colon Smooth Muscle	Colon
11	chr6:150176600-150183400	Weak transcription	Rectal Mucosa Donor 29	rectum
12	chr6:150176800-150183400	Weak transcription	HSMMtube	muscle
13	chr6:150177200-150183000	Weak transcription	Fetal Kidney	kidney
14	chr6:150177600-150183000	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
15	chr6:150177600-150183200	Weak transcription	Fetal Lung	lung
16	chr6:150178000-150183200	Weak transcription	H9 Cell Line	embryonic stem cell
17	chr6:150178000-150183200	Weak transcription	Rectal Mucosa Donor 31	rectum
18	chr6:150178600-150184000	Weak transcription	Psoas Muscle	Psoas
19	chr6:150178800-150183400	Weak transcription	Placenta Amnion	Placenta Amnion
20	chr6:150179000-150183200	Weak transcription	HSMM	muscle
21	chr6:150179600-150183200	Enhancers	Muscle Satellite Cultured Cells	--
22	chr6:150180200-150183400	Enhancers	Skeletal Muscle Female	skeletal muscle
23	chr6:150180600-150182800	Enhancers	Skeletal Muscle Male	skeletal muscle
24	chr6:150180600-150183200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
25	chr6:150180600-150183600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
26	chr6:150180600-150183600	Enhancers	Gastric	stomach
27	chr6:150180600-150184200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
28	chr6:150180800-150183200	Enhancers	HUES48 Cell Line	embryonic stem cell
29	chr6:150181200-150182800	Enhancers	Right Ventricle	heart
30	chr6:150181200-150183000	Enhancers	Brain Inferior Temporal Lobe	brain
31	chr6:150181200-150183600	Enhancers	Esophagus	oesophagus
32	chr6:150181200-150183800	Enhancers	Fetal Muscle Leg	muscle
33	chr6:150181200-150183800	Enhancers	Placenta	Placenta
34	chr6:150181200-150183800	Enhancers	Pancreas	Pancrea
35	chr6:150181200-150183800	Flanking Active TSS	Hela-S3	cervix
36	chr6:150181200-150184000	Enhancers	Liver	Liver
37	chr6:150181400-150183000	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
38	chr6:150181400-150183400	Enhancers	HMEC	breast
39	chr6:150181600-150183000	Flanking Active TSS	A549	lung
40	chr6:150181600-150183200	Genic enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
41	chr6:150181600-150183400	Strong transcription	Fetal Stomach	stomach
42	chr6:150181800-150182600	Genic enhancers	Fetal Brain Female	brain
43	chr6:150181800-150182600	Genic enhancers	NHEK	skin
44	chr6:150181800-150183000	Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
45	chr6:150181800-150183200	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
46	chr6:150181800-150183200	Enhancers	Brain Hippocampus Middle	brain
47	chr6:150181800-150183800	Enhancers	Adipose Nuclei	Adipose
48	chr6:150181800-150183800	Enhancers	Brain Germinal Matrix	brain
49	chr6:150182000-150182600	Flanking Bivalent TSS/Enh	HepG2	liver
50	chr6:150182000-150182800	Genic enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links